Advertisement
Advertisement

IMDX

IMDX logo

Insight Molecular Diagnostics Inc. Common Stock

5.38
USD
Sponsored
+0.01
+0.19%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

5.41

+0.03
+0.56%

Insight Molecular Diagnostics Inc. Common Stock Profile

About

Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn.

Info & Links

CEO

JOSHUA RIGGS

Headquarters

2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217, UNITED STATES

Industry

Medical Info Systems

Sector

Medical

Website

https://imdxinc.com/

Auditor

Marcum LLP

Share holders

170

Employees

58

Insight Molecular Diagnostics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

174.69M

Enterprise Value

147.52M

Enterprise Value/EBITDA(ttm)

-3.18

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

25.23

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

56.37%

Operating Margin(ttm)

-888.19%

Profit Margin(ttm)

-2095.67%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-991.28%

Return on Assets(ttm)

-79.78%

Income Statement

Revenue(ttm)

1.95M

Revenue Per Share(ttm)

0.06

Gross Profit(ttm)

988.00K

EBITDA(ttm)3

-46.40M

Net Income Available to Common(ttm)

-47.84M

Diluted EPS(ttm)

-1.62

Share Statistics

Beta (5Y Monthly)

1.52

52-Week Change

46.99%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

32.29M

Dividend Yield

0.00%

Float4

31.51M

% Held by Insiders

2.05%

% Held by Institutions

55.35%

Balance Sheet

Total Cash(mrq)

28.93M

Total Cash Per Share(mrq)

0.90

Total Debt(mrq)

1.76M

Total Debt/Equity(mrq)

-143.48%

Current Ratio(mrq)

1.27%

Quick Ratio(mrq)

1.23%

Book Value Per Share(mrq)

-1.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.73

Free Cash Flow(ytd)

-25.37M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement